Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
002317.SZ
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q1.23
+0%
0.09
vs 0.09
Q1.23
N/A
0.09
vs 0.09
Q2.23
-47%
0.08
vs 0.15
Q3.23
+37%
0.08
vs 0.06
Q4.23
N/A
-0.02
vs NA
Q1.24
-33%
0.06
vs 0.09
Q2.24
-48%
0.04
vs 0.08
Q3.24
-3%
0.08
vs 0.08
Q4.24
N/A
-0.54
vs -0.02
Q1.25
+67%
0.1
vs 0.06
Sales Growth
YoY
Current
Estimates
Q1.23
+1%
684.9M vs 675.8M
Q1.23
+11%
746.8M vs 675.8M
Q2.23
+13%
735.5M vs 650.1M
Q3.23
-11%
589M vs 665.3M
Q4.23
NA
539.3M vs NA
Q1.24
-14%
641.1M vs 746.8M
Q2.24
-2%
723.2M vs 735.5M
Q3.24
-8%
543.7M vs 589M
Q4.24
+4%
559.4M vs 539.3M
Q1.25
-1%
634.3M vs 641.1M
Return on Equity
QoQ
Q2.23
+2%
0.02
vs 0.04
Q3.23
+2%
0.02
vs 0.02
Q4.23
0%
-0.00
vs 0.02
Q1.24
+1%
0.01
vs -0.00
Q2.24
+1%
0.01
vs 0.01
Q3.24
+1%
0.01
vs 0.01
Q4.24
-11%
-0.11
vs 0.01
Q1.25
+2%
0.02
vs -0.11
Institutionnal Ownership
Forecast
399%2026-Revenue
345%2026-EPS
140%2026-EBITDA
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Price Target
NaN(-100.00%)
Number of analyst
Last analyst upgrade/downgrade
No Data Available
Relative Strength
002317.SZ
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Guangdong Zhongsheng Pharmaceutical Co., Ltd. researches, develops, produces, and sells pharmaceutical products in China. The company offers Chinese and chemical medicines. It is also involved in the research and development of products in the fields of ophthalmology, cardiovascular, cerebrovascular, respiratory, digestive, diabetes, tumor, and senile degenerative diseases. The company was founded in 1979 and is based in Dongguan, China.
SHZ
Unprofitable
EPS improving
Unprofitable
EPS improving
0.31Â ( 1.98%)
Relative Strenght
Volume Buzz
18%
Earning Acce
No
Dist 52w H.
13%Quote Panel
Key Metrics
Fundamentals
P/E Ratio
P/S Ratio
P/B Ratio
Debt/Equity
Net Margin
EPS
How 002317.SZ compares to sector?